Mustafa Emirik

8PUBLICATIONS
9CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 27, 2026
Design, Synthesis, and Evaluation of Novel Adenine-Based Hydrazones as Potential Anticancer Agents: Cytotoxicity Against A549 and MRC-5 Cell Lines with In Silico Insights.

|Oct 09, 2026
Design, Synthesis, and Anticancer Evaluation of Novel Chalcone Derivatives Bearing Piperazine and Morpholine Moieties.

|Aug 27, 2026
Trifluoromethyl-Benzimidazole-Hydrazone Derivatives as Promising Selective Anticancer Agents: Synthesis, Cytotoxicity, and Molecular Docking Insights.

|Aug 20, 2026
Design, Synthesis, and Biological Evaluation of Benzimidazol-2-One Hybrids as Potential Anti-Alzheimer's Disease Agents.

|Mar 28, 2026
Novel Adenine-Hydrazone Hybrids Against Human Lung Adenocarcinoma (A549): Design, Synthesis, Cellular Mechanistic Investigation and Molecular Docking Studies.

Emre Menteşe, Nedime Çalışkan, Didem Aksu

|Dec 31, 2025
Evaluation of Antiproliferative Activity and Molecular Modeling Studies of Some Novel Benzimidazolone-Bridged Hybrid Compounds.

Okan Güven, Emre Menteşe, Fatih Yılmaz

Pageof 2

Frequent Collaborators

5 joint publications

Emre Menteşe

4 joint publications

Fatih Yılmaz

3 joint publications

Adem Güner

2 joint publications

Musa Özil